To overcome the lack of activity of exogenous TRAIL ligands, Allen et al. conducted a screen using a colon cancer cell line to identify small molecules in a National Cancer Institute (NCI) chemical library that could induce TRAIL on tumor cells and thereby activate TRAIL receptors via an autocrine or paracrine mechanism [5]. The gene discussed is TNFSF10; the disease is neoplasm.